Integrated Diagnostics to Present Additional Data Analyses from PANOPTIC study at American Thoracic Society (ATS) International Conference 2018
May 14, 2018 07:30 ET
|
Indi Integrated Diagnostics, Inc. (IndiDx)
SEATTLE, May 14, 2018 (GLOBE NEWSWIRE) -- Integrated Diagnostics (“Indi”) today announced that it will provide additional results to validate the accuracy of its Xpresys Lung 2® integrated...
Xpresys Lung 2, the first liquid biopsy for the differential diagnosis of early stage lung cancer, validated by study published in CHEST
February 28, 2018 12:35 ET
|
Indi Integrated Diagnostics, Inc. (IndiDx)
Addresses significant unmet need to identify benign lung nodules, with high probability, to avoid unnecessary invasive procedures. Clinical validation was based on the PANOTPIC clinical trial, a...